Aurinia Pharmaceuticals's (AUPH) Outperform Rating Reiterated at FBR Following AURA-LV Phase IIb Data
Go back to Aurinia Pharmaceuticals's (AUPH) Outperform Rating Reiterated at FBR Following AURA-LV Phase IIb Data(NASDAQ: AUPH) | Delayed: 4.81 -0.1 (2.04%) | |||||
---|---|---|---|---|---|---|
Previous Close | $4.91 | 52 Week High | $5.69 | |||
Open | $4.91 | 52 Week Low | $1.42 | |||
Day High | $4.96 | P/E | N/A | |||
Day Low | $4.71 | EPS | $0.00 | |||
Volume | 2,097,931 |